In Vitro Activity of AR-709 against Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

We investigated the in vitro activity of AR-709, a novel diaminopyrimidine antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries. AR-709 showed excellent activity against both drug-susceptible and multidrug-resistant pneumococci.

Knowledge Graph

Similar Paper

In Vitro Activity of AR-709 against Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2008.0
Activity of the Diaminopyrimidine AR-709 against Recently Collected Multidrug-Resistant Isolates of Invasive Streptococcus pneumoniae from North America
Antimicrobial Agents and Chemotherapy 2008.0
Antistreptococcal Activity of AR-709 Compared to That of Other Agents
Antimicrobial Agents and Chemotherapy 2008.0
Synthesis and antibacterial activity of new 9-O-arylpropenyloxime ketolides
Bioorganic & Medicinal Chemistry Letters 2010.0
In Vitro Activity of Iclaprim against Respiratory and Bacteremic Isolates of Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2009.0
Novel C-4″ modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumoniae: The synthesis and antimicrobial evaluation
European Journal of Medicinal Chemistry 2011.0
Synthesis and antibacterial activity of 4″-O-(trans-β-arylacrylamido)carbamoyl azithromycin analogs
European Journal of Medicinal Chemistry 2015.0
Synthesis and antibacterial activity of novel 4″-O-arylalkylcarbamoyl and 4″-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and antibacterial activity of 4″,11-di-O-arylalkylcarbamoyl azithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2018.0